Skip to main content

Table 2 Number of genes over-expressed in xenografts excised from GLV-1h68 infected animals

From: Systemic treatment of xenografts with vaccinia virus GLV-1h68 reveals the immunologic facet of oncolytic therapy

Experimental group

Days after VACV inj.

    

VACGLa 520445F, Affymetrix platform

VACV only

Permutation

House keeping (human/mouse)

Permutation

(cut off p2-value < 0.005 (unpaired Student t test)

 

(∑ 219)

test p-value

(∑ 337)

test p-value

GI-101A

7

0

N.S.

3

N.S.

GI-101A

21

219

< 0.001

(232)

< 0.001

GI-101A

42

216

< 0.001

(237)

< 0.001

HT-29

21

0

N.S.

(3)

N.S.

HT-29

42

0

N.S.

(10)

N.S.

37 K whole genome HUMAN array

 

All genes

Permutation

  

(cut off p2-value < 0.001 (unpaired Student t test)

 

(∑ 37 K)

test p-value

  

GI-101A

21

136

< 0.05

  

GI-101A

42

91

< 0.05

  

HT-29

21

4

N.S.

  

HT-29

42

10

N.S.

  

37 K whole genome Mouse array

 

All genes

Permutation

  

(cut off p2-value < 0.001 (unpaired Student t test)

 

(∑ 37 K)

test p-value

  

GI-101A

21

105

< 0.05

  

GI-101A

42

1026

< 0.001

  

HT-29

21

7

N.S.

  

HT-29

42

14

N.S.

  
  1. * In parenthesis, genes down-regulated in GLV-1h68-infected animals referring to human/mouse house-keeping genes in the VACV chip